NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition [Seeking Alpha]
Celularity Inc. - Class A (CELU)
Company Research
Source: Seeking Alpha
"On today's call, I will discuss our announcement this morning regarding the closing of our transaction to acquire Celularity's degenerative wound segment." (CEO, President & Director Adam Levy) "This is a Fresh Stock Ideas, Every Day Quick Insights Management projects tripling pro forma revenue to approximately $35 million and immediate EBITDA profitability after acquiring Celularity's degenerative wound segment. The $5.5 million convertible note carries a risk if performance falters, potentially 'turning ugly,' with dilution concerns and an 18-month term at a 10% coupon and 50% warrant coverage. Management anticipates seamless operational integration with no significant extra costs, but emphasizes focus on asset integration and commercial growth execution, alongside ongoing mitigation of near-term product and consumer volatility risks. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
CELU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELU alerts
High impacting Celularity Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CELU
News
- Celularity Announces Closing of Transaction with NexGelGlobeNewswire
- Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingGlobeNewswire
- NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction [Yahoo! Finance]Yahoo! Finance
- Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product OpportunitiesGlobeNewswire
- Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy [Yahoo! Finance]Yahoo! Finance
CELU
Sec Filings
- 4/24/26 - Form 3
- 4/24/26 - Form 3
- 4/24/26 - Form 3
- CELU's page on the SEC website